Global Convalescent Plasma Therapy Market Research Report 2024(Status and Outlook)
Report Overview
Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism.
This report provides a deep insight into the global Convalescent Plasma Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Convalescent Plasma Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Convalescent Plasma Therapy market in any manner.
Global Convalescent Plasma Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bio Farma
Grifols
Hilton Pharma
Biotest
BPL
LFB
Octapharma
CSL Behring
Takeda Pharmaceutical Company Limited
Orthosera Kft
Market Segmentation (by Type)
IgM
IgG
IgA
Market Segmentation (by Application)
Prophylaxis
Treatment
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Convalescent Plasma Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism.
This report provides a deep insight into the global Convalescent Plasma Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Convalescent Plasma Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Convalescent Plasma Therapy market in any manner.
Global Convalescent Plasma Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bio Farma
Grifols
Hilton Pharma
Biotest
BPL
LFB
Octapharma
CSL Behring
Takeda Pharmaceutical Company Limited
Orthosera Kft
Market Segmentation (by Type)
IgM
IgG
IgA
Market Segmentation (by Application)
Prophylaxis
Treatment
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Convalescent Plasma Therapy Market
- Overview of the regional outlook of the Convalescent Plasma Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Convalescent Plasma Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Convalescent Plasma Therapy
1.2 Key Market Segments
1.2.1 Convalescent Plasma Therapy Segment by Type
1.2.2 Convalescent Plasma Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CONVALESCENT PLASMA THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Convalescent Plasma Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Convalescent Plasma Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CONVALESCENT PLASMA THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Convalescent Plasma Therapy Sales by Manufacturers (2019-2024)
3.2 Global Convalescent Plasma Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Convalescent Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Convalescent Plasma Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Convalescent Plasma Therapy Sales Sites, Area Served, Product Type
3.6 Convalescent Plasma Therapy Market Competitive Situation and Trends
3.6.1 Convalescent Plasma Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Convalescent Plasma Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CONVALESCENT PLASMA THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Convalescent Plasma Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CONVALESCENT PLASMA THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CONVALESCENT PLASMA THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Convalescent Plasma Therapy Sales Market Share by Type (2019-2024)
6.3 Global Convalescent Plasma Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Convalescent Plasma Therapy Price by Type (2019-2024)
7 CONVALESCENT PLASMA THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Convalescent Plasma Therapy Market Sales by Application (2019-2024)
7.3 Global Convalescent Plasma Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Convalescent Plasma Therapy Sales Growth Rate by Application (2019-2024)
8 CONVALESCENT PLASMA THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Convalescent Plasma Therapy Sales by Region
8.1.1 Global Convalescent Plasma Therapy Sales by Region
8.1.2 Global Convalescent Plasma Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Convalescent Plasma Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Convalescent Plasma Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Convalescent Plasma Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Convalescent Plasma Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Convalescent Plasma Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bio Farma
9.1.1 Bio Farma Convalescent Plasma Therapy Basic Information
9.1.2 Bio Farma Convalescent Plasma Therapy Product Overview
9.1.3 Bio Farma Convalescent Plasma Therapy Product Market Performance
9.1.4 Bio Farma Business Overview
9.1.5 Bio Farma Convalescent Plasma Therapy SWOT Analysis
9.1.6 Bio Farma Recent Developments
9.2 Grifols
9.2.1 Grifols Convalescent Plasma Therapy Basic Information
9.2.2 Grifols Convalescent Plasma Therapy Product Overview
9.2.3 Grifols Convalescent Plasma Therapy Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Convalescent Plasma Therapy SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Hilton Pharma
9.3.1 Hilton Pharma Convalescent Plasma Therapy Basic Information
9.3.2 Hilton Pharma Convalescent Plasma Therapy Product Overview
9.3.3 Hilton Pharma Convalescent Plasma Therapy Product Market Performance
9.3.4 Hilton Pharma Convalescent Plasma Therapy SWOT Analysis
9.3.5 Hilton Pharma Business Overview
9.3.6 Hilton Pharma Recent Developments
9.4 Biotest
9.4.1 Biotest Convalescent Plasma Therapy Basic Information
9.4.2 Biotest Convalescent Plasma Therapy Product Overview
9.4.3 Biotest Convalescent Plasma Therapy Product Market Performance
9.4.4 Biotest Business Overview
9.4.5 Biotest Recent Developments
9.5 BPL
9.5.1 BPL Convalescent Plasma Therapy Basic Information
9.5.2 BPL Convalescent Plasma Therapy Product Overview
9.5.3 BPL Convalescent Plasma Therapy Product Market Performance
9.5.4 BPL Business Overview
9.5.5 BPL Recent Developments
9.6 LFB
9.6.1 LFB Convalescent Plasma Therapy Basic Information
9.6.2 LFB Convalescent Plasma Therapy Product Overview
9.6.3 LFB Convalescent Plasma Therapy Product Market Performance
9.6.4 LFB Business Overview
9.6.5 LFB Recent Developments
9.7 Octapharma
9.7.1 Octapharma Convalescent Plasma Therapy Basic Information
9.7.2 Octapharma Convalescent Plasma Therapy Product Overview
9.7.3 Octapharma Convalescent Plasma Therapy Product Market Performance
9.7.4 Octapharma Business Overview
9.7.5 Octapharma Recent Developments
9.8 CSL Behring
9.8.1 CSL Behring Convalescent Plasma Therapy Basic Information
9.8.2 CSL Behring Convalescent Plasma Therapy Product Overview
9.8.3 CSL Behring Convalescent Plasma Therapy Product Market Performance
9.8.4 CSL Behring Business Overview
9.8.5 CSL Behring Recent Developments
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Basic Information
9.9.2 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product Overview
9.9.3 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product Market Performance
9.9.4 Takeda Pharmaceutical Company Limited Business Overview
9.9.5 Takeda Pharmaceutical Company Limited Recent Developments
9.10 Orthosera Kft
9.10.1 Orthosera Kft Convalescent Plasma Therapy Basic Information
9.10.2 Orthosera Kft Convalescent Plasma Therapy Product Overview
9.10.3 Orthosera Kft Convalescent Plasma Therapy Product Market Performance
9.10.4 Orthosera Kft Business Overview
9.10.5 Orthosera Kft Recent Developments
10 CONVALESCENT PLASMA THERAPY MARKET FORECAST BY REGION
10.1 Global Convalescent Plasma Therapy Market Size Forecast
10.2 Global Convalescent Plasma Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Convalescent Plasma Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Convalescent Plasma Therapy Market Size Forecast by Region
10.2.4 South America Convalescent Plasma Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Convalescent Plasma Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Convalescent Plasma Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Convalescent Plasma Therapy by Type (2025-2030)
11.1.2 Global Convalescent Plasma Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Convalescent Plasma Therapy by Type (2025-2030)
11.2 Global Convalescent Plasma Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Convalescent Plasma Therapy Sales (K Units) Forecast by Application
11.2.2 Global Convalescent Plasma Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Convalescent Plasma Therapy
1.2 Key Market Segments
1.2.1 Convalescent Plasma Therapy Segment by Type
1.2.2 Convalescent Plasma Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CONVALESCENT PLASMA THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Convalescent Plasma Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Convalescent Plasma Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CONVALESCENT PLASMA THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Convalescent Plasma Therapy Sales by Manufacturers (2019-2024)
3.2 Global Convalescent Plasma Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Convalescent Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Convalescent Plasma Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Convalescent Plasma Therapy Sales Sites, Area Served, Product Type
3.6 Convalescent Plasma Therapy Market Competitive Situation and Trends
3.6.1 Convalescent Plasma Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Convalescent Plasma Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CONVALESCENT PLASMA THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Convalescent Plasma Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CONVALESCENT PLASMA THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CONVALESCENT PLASMA THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Convalescent Plasma Therapy Sales Market Share by Type (2019-2024)
6.3 Global Convalescent Plasma Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Convalescent Plasma Therapy Price by Type (2019-2024)
7 CONVALESCENT PLASMA THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Convalescent Plasma Therapy Market Sales by Application (2019-2024)
7.3 Global Convalescent Plasma Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Convalescent Plasma Therapy Sales Growth Rate by Application (2019-2024)
8 CONVALESCENT PLASMA THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Convalescent Plasma Therapy Sales by Region
8.1.1 Global Convalescent Plasma Therapy Sales by Region
8.1.2 Global Convalescent Plasma Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Convalescent Plasma Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Convalescent Plasma Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Convalescent Plasma Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Convalescent Plasma Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Convalescent Plasma Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bio Farma
9.1.1 Bio Farma Convalescent Plasma Therapy Basic Information
9.1.2 Bio Farma Convalescent Plasma Therapy Product Overview
9.1.3 Bio Farma Convalescent Plasma Therapy Product Market Performance
9.1.4 Bio Farma Business Overview
9.1.5 Bio Farma Convalescent Plasma Therapy SWOT Analysis
9.1.6 Bio Farma Recent Developments
9.2 Grifols
9.2.1 Grifols Convalescent Plasma Therapy Basic Information
9.2.2 Grifols Convalescent Plasma Therapy Product Overview
9.2.3 Grifols Convalescent Plasma Therapy Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Convalescent Plasma Therapy SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Hilton Pharma
9.3.1 Hilton Pharma Convalescent Plasma Therapy Basic Information
9.3.2 Hilton Pharma Convalescent Plasma Therapy Product Overview
9.3.3 Hilton Pharma Convalescent Plasma Therapy Product Market Performance
9.3.4 Hilton Pharma Convalescent Plasma Therapy SWOT Analysis
9.3.5 Hilton Pharma Business Overview
9.3.6 Hilton Pharma Recent Developments
9.4 Biotest
9.4.1 Biotest Convalescent Plasma Therapy Basic Information
9.4.2 Biotest Convalescent Plasma Therapy Product Overview
9.4.3 Biotest Convalescent Plasma Therapy Product Market Performance
9.4.4 Biotest Business Overview
9.4.5 Biotest Recent Developments
9.5 BPL
9.5.1 BPL Convalescent Plasma Therapy Basic Information
9.5.2 BPL Convalescent Plasma Therapy Product Overview
9.5.3 BPL Convalescent Plasma Therapy Product Market Performance
9.5.4 BPL Business Overview
9.5.5 BPL Recent Developments
9.6 LFB
9.6.1 LFB Convalescent Plasma Therapy Basic Information
9.6.2 LFB Convalescent Plasma Therapy Product Overview
9.6.3 LFB Convalescent Plasma Therapy Product Market Performance
9.6.4 LFB Business Overview
9.6.5 LFB Recent Developments
9.7 Octapharma
9.7.1 Octapharma Convalescent Plasma Therapy Basic Information
9.7.2 Octapharma Convalescent Plasma Therapy Product Overview
9.7.3 Octapharma Convalescent Plasma Therapy Product Market Performance
9.7.4 Octapharma Business Overview
9.7.5 Octapharma Recent Developments
9.8 CSL Behring
9.8.1 CSL Behring Convalescent Plasma Therapy Basic Information
9.8.2 CSL Behring Convalescent Plasma Therapy Product Overview
9.8.3 CSL Behring Convalescent Plasma Therapy Product Market Performance
9.8.4 CSL Behring Business Overview
9.8.5 CSL Behring Recent Developments
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Basic Information
9.9.2 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product Overview
9.9.3 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product Market Performance
9.9.4 Takeda Pharmaceutical Company Limited Business Overview
9.9.5 Takeda Pharmaceutical Company Limited Recent Developments
9.10 Orthosera Kft
9.10.1 Orthosera Kft Convalescent Plasma Therapy Basic Information
9.10.2 Orthosera Kft Convalescent Plasma Therapy Product Overview
9.10.3 Orthosera Kft Convalescent Plasma Therapy Product Market Performance
9.10.4 Orthosera Kft Business Overview
9.10.5 Orthosera Kft Recent Developments
10 CONVALESCENT PLASMA THERAPY MARKET FORECAST BY REGION
10.1 Global Convalescent Plasma Therapy Market Size Forecast
10.2 Global Convalescent Plasma Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Convalescent Plasma Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Convalescent Plasma Therapy Market Size Forecast by Region
10.2.4 South America Convalescent Plasma Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Convalescent Plasma Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Convalescent Plasma Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Convalescent Plasma Therapy by Type (2025-2030)
11.1.2 Global Convalescent Plasma Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Convalescent Plasma Therapy by Type (2025-2030)
11.2 Global Convalescent Plasma Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Convalescent Plasma Therapy Sales (K Units) Forecast by Application
11.2.2 Global Convalescent Plasma Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Convalescent Plasma Therapy Market Size Comparison by Region (M USD)
Table 5. Global Convalescent Plasma Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Convalescent Plasma Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Convalescent Plasma Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Convalescent Plasma Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Convalescent Plasma Therapy as of 2022)
Table 10. Global Market Convalescent Plasma Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Convalescent Plasma Therapy Sales Sites and Area Served
Table 12. Manufacturers Convalescent Plasma Therapy Product Type
Table 13. Global Convalescent Plasma Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Convalescent Plasma Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Convalescent Plasma Therapy Market Challenges
Table 22. Global Convalescent Plasma Therapy Sales by Type (K Units)
Table 23. Global Convalescent Plasma Therapy Market Size by Type (M USD)
Table 24. Global Convalescent Plasma Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Convalescent Plasma Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Convalescent Plasma Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Convalescent Plasma Therapy Market Size Share by Type (2019-2024)
Table 28. Global Convalescent Plasma Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Convalescent Plasma Therapy Sales (K Units) by Application
Table 30. Global Convalescent Plasma Therapy Market Size by Application
Table 31. Global Convalescent Plasma Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Convalescent Plasma Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Convalescent Plasma Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Convalescent Plasma Therapy Market Share by Application (2019-2024)
Table 35. Global Convalescent Plasma Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Convalescent Plasma Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Convalescent Plasma Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Convalescent Plasma Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Convalescent Plasma Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Convalescent Plasma Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Convalescent Plasma Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Convalescent Plasma Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Bio Farma Convalescent Plasma Therapy Basic Information
Table 44. Bio Farma Convalescent Plasma Therapy Product Overview
Table 45. Bio Farma Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Bio Farma Business Overview
Table 47. Bio Farma Convalescent Plasma Therapy SWOT Analysis
Table 48. Bio Farma Recent Developments
Table 49. Grifols Convalescent Plasma Therapy Basic Information
Table 50. Grifols Convalescent Plasma Therapy Product Overview
Table 51. Grifols Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Grifols Business Overview
Table 53. Grifols Convalescent Plasma Therapy SWOT Analysis
Table 54. Grifols Recent Developments
Table 55. Hilton Pharma Convalescent Plasma Therapy Basic Information
Table 56. Hilton Pharma Convalescent Plasma Therapy Product Overview
Table 57. Hilton Pharma Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Hilton Pharma Convalescent Plasma Therapy SWOT Analysis
Table 59. Hilton Pharma Business Overview
Table 60. Hilton Pharma Recent Developments
Table 61. Biotest Convalescent Plasma Therapy Basic Information
Table 62. Biotest Convalescent Plasma Therapy Product Overview
Table 63. Biotest Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Biotest Business Overview
Table 65. Biotest Recent Developments
Table 66. BPL Convalescent Plasma Therapy Basic Information
Table 67. BPL Convalescent Plasma Therapy Product Overview
Table 68. BPL Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BPL Business Overview
Table 70. BPL Recent Developments
Table 71. LFB Convalescent Plasma Therapy Basic Information
Table 72. LFB Convalescent Plasma Therapy Product Overview
Table 73. LFB Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. LFB Business Overview
Table 75. LFB Recent Developments
Table 76. Octapharma Convalescent Plasma Therapy Basic Information
Table 77. Octapharma Convalescent Plasma Therapy Product Overview
Table 78. Octapharma Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Octapharma Business Overview
Table 80. Octapharma Recent Developments
Table 81. CSL Behring Convalescent Plasma Therapy Basic Information
Table 82. CSL Behring Convalescent Plasma Therapy Product Overview
Table 83. CSL Behring Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. CSL Behring Business Overview
Table 85. CSL Behring Recent Developments
Table 86. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Basic Information
Table 87. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product Overview
Table 88. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Takeda Pharmaceutical Company Limited Business Overview
Table 90. Takeda Pharmaceutical Company Limited Recent Developments
Table 91. Orthosera Kft Convalescent Plasma Therapy Basic Information
Table 92. Orthosera Kft Convalescent Plasma Therapy Product Overview
Table 93. Orthosera Kft Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Orthosera Kft Business Overview
Table 95. Orthosera Kft Recent Developments
Table 96. Global Convalescent Plasma Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Convalescent Plasma Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Convalescent Plasma Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Convalescent Plasma Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Convalescent Plasma Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Convalescent Plasma Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Convalescent Plasma Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Convalescent Plasma Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Convalescent Plasma Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Convalescent Plasma Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Convalescent Plasma Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Convalescent Plasma Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Convalescent Plasma Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Convalescent Plasma Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Convalescent Plasma Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Convalescent Plasma Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Convalescent Plasma Therapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Convalescent Plasma Therapy Market Size Comparison by Region (M USD)
Table 5. Global Convalescent Plasma Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Convalescent Plasma Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Convalescent Plasma Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Convalescent Plasma Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Convalescent Plasma Therapy as of 2022)
Table 10. Global Market Convalescent Plasma Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Convalescent Plasma Therapy Sales Sites and Area Served
Table 12. Manufacturers Convalescent Plasma Therapy Product Type
Table 13. Global Convalescent Plasma Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Convalescent Plasma Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Convalescent Plasma Therapy Market Challenges
Table 22. Global Convalescent Plasma Therapy Sales by Type (K Units)
Table 23. Global Convalescent Plasma Therapy Market Size by Type (M USD)
Table 24. Global Convalescent Plasma Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Convalescent Plasma Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Convalescent Plasma Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Convalescent Plasma Therapy Market Size Share by Type (2019-2024)
Table 28. Global Convalescent Plasma Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Convalescent Plasma Therapy Sales (K Units) by Application
Table 30. Global Convalescent Plasma Therapy Market Size by Application
Table 31. Global Convalescent Plasma Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Convalescent Plasma Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Convalescent Plasma Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Convalescent Plasma Therapy Market Share by Application (2019-2024)
Table 35. Global Convalescent Plasma Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Convalescent Plasma Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Convalescent Plasma Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Convalescent Plasma Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Convalescent Plasma Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Convalescent Plasma Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Convalescent Plasma Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Convalescent Plasma Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Bio Farma Convalescent Plasma Therapy Basic Information
Table 44. Bio Farma Convalescent Plasma Therapy Product Overview
Table 45. Bio Farma Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Bio Farma Business Overview
Table 47. Bio Farma Convalescent Plasma Therapy SWOT Analysis
Table 48. Bio Farma Recent Developments
Table 49. Grifols Convalescent Plasma Therapy Basic Information
Table 50. Grifols Convalescent Plasma Therapy Product Overview
Table 51. Grifols Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Grifols Business Overview
Table 53. Grifols Convalescent Plasma Therapy SWOT Analysis
Table 54. Grifols Recent Developments
Table 55. Hilton Pharma Convalescent Plasma Therapy Basic Information
Table 56. Hilton Pharma Convalescent Plasma Therapy Product Overview
Table 57. Hilton Pharma Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Hilton Pharma Convalescent Plasma Therapy SWOT Analysis
Table 59. Hilton Pharma Business Overview
Table 60. Hilton Pharma Recent Developments
Table 61. Biotest Convalescent Plasma Therapy Basic Information
Table 62. Biotest Convalescent Plasma Therapy Product Overview
Table 63. Biotest Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Biotest Business Overview
Table 65. Biotest Recent Developments
Table 66. BPL Convalescent Plasma Therapy Basic Information
Table 67. BPL Convalescent Plasma Therapy Product Overview
Table 68. BPL Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BPL Business Overview
Table 70. BPL Recent Developments
Table 71. LFB Convalescent Plasma Therapy Basic Information
Table 72. LFB Convalescent Plasma Therapy Product Overview
Table 73. LFB Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. LFB Business Overview
Table 75. LFB Recent Developments
Table 76. Octapharma Convalescent Plasma Therapy Basic Information
Table 77. Octapharma Convalescent Plasma Therapy Product Overview
Table 78. Octapharma Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Octapharma Business Overview
Table 80. Octapharma Recent Developments
Table 81. CSL Behring Convalescent Plasma Therapy Basic Information
Table 82. CSL Behring Convalescent Plasma Therapy Product Overview
Table 83. CSL Behring Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. CSL Behring Business Overview
Table 85. CSL Behring Recent Developments
Table 86. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Basic Information
Table 87. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product Overview
Table 88. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Takeda Pharmaceutical Company Limited Business Overview
Table 90. Takeda Pharmaceutical Company Limited Recent Developments
Table 91. Orthosera Kft Convalescent Plasma Therapy Basic Information
Table 92. Orthosera Kft Convalescent Plasma Therapy Product Overview
Table 93. Orthosera Kft Convalescent Plasma Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Orthosera Kft Business Overview
Table 95. Orthosera Kft Recent Developments
Table 96. Global Convalescent Plasma Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Convalescent Plasma Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Convalescent Plasma Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Convalescent Plasma Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Convalescent Plasma Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Convalescent Plasma Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Convalescent Plasma Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Convalescent Plasma Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Convalescent Plasma Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Convalescent Plasma Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Convalescent Plasma Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Convalescent Plasma Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Convalescent Plasma Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Convalescent Plasma Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Convalescent Plasma Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Convalescent Plasma Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Convalescent Plasma Therapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Convalescent Plasma Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Convalescent Plasma Therapy Market Size (M USD), 2019-2030
Figure 5. Global Convalescent Plasma Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Convalescent Plasma Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Convalescent Plasma Therapy Market Size by Country (M USD)
Figure 11. Convalescent Plasma Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Convalescent Plasma Therapy Revenue Share by Manufacturers in 2023
Figure 13. Convalescent Plasma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Convalescent Plasma Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Convalescent Plasma Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Convalescent Plasma Therapy Market Share by Type
Figure 18. Sales Market Share of Convalescent Plasma Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Convalescent Plasma Therapy by Type in 2023
Figure 20. Market Size Share of Convalescent Plasma Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Convalescent Plasma Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Convalescent Plasma Therapy Market Share by Application
Figure 24. Global Convalescent Plasma Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Convalescent Plasma Therapy Sales Market Share by Application in 2023
Figure 26. Global Convalescent Plasma Therapy Market Share by Application (2019-2024)
Figure 27. Global Convalescent Plasma Therapy Market Share by Application in 2023
Figure 28. Global Convalescent Plasma Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Convalescent Plasma Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Convalescent Plasma Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Convalescent Plasma Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Convalescent Plasma Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Convalescent Plasma Therapy Sales Market Share by Country in 2023
Figure 37. Germany Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Convalescent Plasma Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Convalescent Plasma Therapy Sales Market Share by Region in 2023
Figure 44. China Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Convalescent Plasma Therapy Sales and Growth Rate (K Units)
Figure 50. South America Convalescent Plasma Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Convalescent Plasma Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Convalescent Plasma Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Convalescent Plasma Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Convalescent Plasma Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Convalescent Plasma Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Convalescent Plasma Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Convalescent Plasma Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Convalescent Plasma Therapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Convalescent Plasma Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Convalescent Plasma Therapy Market Size (M USD), 2019-2030
Figure 5. Global Convalescent Plasma Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Convalescent Plasma Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Convalescent Plasma Therapy Market Size by Country (M USD)
Figure 11. Convalescent Plasma Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Convalescent Plasma Therapy Revenue Share by Manufacturers in 2023
Figure 13. Convalescent Plasma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Convalescent Plasma Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Convalescent Plasma Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Convalescent Plasma Therapy Market Share by Type
Figure 18. Sales Market Share of Convalescent Plasma Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Convalescent Plasma Therapy by Type in 2023
Figure 20. Market Size Share of Convalescent Plasma Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Convalescent Plasma Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Convalescent Plasma Therapy Market Share by Application
Figure 24. Global Convalescent Plasma Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Convalescent Plasma Therapy Sales Market Share by Application in 2023
Figure 26. Global Convalescent Plasma Therapy Market Share by Application (2019-2024)
Figure 27. Global Convalescent Plasma Therapy Market Share by Application in 2023
Figure 28. Global Convalescent Plasma Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Convalescent Plasma Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Convalescent Plasma Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Convalescent Plasma Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Convalescent Plasma Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Convalescent Plasma Therapy Sales Market Share by Country in 2023
Figure 37. Germany Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Convalescent Plasma Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Convalescent Plasma Therapy Sales Market Share by Region in 2023
Figure 44. China Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Convalescent Plasma Therapy Sales and Growth Rate (K Units)
Figure 50. South America Convalescent Plasma Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Convalescent Plasma Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Convalescent Plasma Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Convalescent Plasma Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Convalescent Plasma Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Convalescent Plasma Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Convalescent Plasma Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Convalescent Plasma Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Convalescent Plasma Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Convalescent Plasma Therapy Market Share Forecast by Application (2025-2030)
